OXB-301

DB19269InvestigationalVaccines

OXB-301 is under investigation in clinical trial NCT00397345 (Trovax Renal Immunotherapy Survival Trial).

Mechanism
Curator reviewed
Also known as
Modified vaccinia virus ankara-5t4 antigen · Trovax
Code names
MVA-5T4 · OXB-301

Resolves to

Compound
UNIIP258UUW1OD
Targets
Q13641TPBG

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with OXB-301, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In